I am very proud to be speaking at two events. The luncheons are hosted by Family Office Networks. Hence, I am presenting both presentations regarding how my company, Advanced Bifurcation Systems has created the only stenting technology that will cover all types of bifurcations.
The first engagement is on September 27th at The Barrel Room in San Francisco. The topic is the Paradigm Shift in Interventional Cardiology. You can RSVP here.
Likewise, the second engagement is on October 17th at Lucques in West Hollywood. In turn, the topic for this one is Bifurcation Disease for a Disruptive Technology; How the Mother-Daughter Solution for all bifurcations. You may RSVP here.
Proud to Have Dick Cheney With Us
We are very much looking forward to our exhibit at the tct2018 convention in San Diego. My company Advanced Bifurcation Systems is proud to have Dick Cheney join us at our booth.
The convention is put on by the Cardiovascular Research Foundation. Located at the San Diego Convention Center on September 21st through the 25th.
CVD is the Worlds Leading Killer…By Far
Cardiovascular disease is our number one public health challenge and more people die annually from CVDs than from any other cause. The World Health Organization estimates that 17.7 million people died from CVDs in 2015. This is nearly third of all global deaths. This includes an estimated 7.4 million deaths from coronary heart disease and 6.7 million from stroke.
Innovation Is the engine for Change and Investors and Entrepreneur provide the Fuel and Spark
Advanced Bifurcation Systems has developed a novel, potentially revolutionary mother-daughter coronary stenting platform that has the potential to reduce the duration of stenting procedures, improve the reliability of bifurcation disease stenting and simplify the procedure for practitioners. So I am presenting at noon this Thursday, August 23rd in at the 2018 Southern California Investor Conference. The conference will be at the Balboa Bay Resort in Newport Beach. I am expecting up to 300 investors will come and hear about the opportunity.
Analysts report that the coronary stent market is expected to reach $10B in 2025. Bifurcation disease could be about 25% of this market. ABS represents a great opportunity for family office investors who seek to make a real impact on the future of healthcare. So as Family Office Networks Founder Andrew Schneider recently put it, “We believe ABS is poised to capture a significant part of this $2.5B market as the only true and complete bifurcating stent delivery platform in the market.”
I hope you will join us
Thursday, August 23rd
Balboa Bay Resort, Newport Beach
Last Untapped Market
The Last Untapped Market Event starts today at noon and we here at ABS are very excited to meet new people and network. ABS is very proud to be a part of FON goals.
Family Office Networks brings people and companies together. Check them out here.
My company has partnered with Family Office Networks. We are happy to be a part of their goals.
We are holding an event at Flemings Steakhouse in Newport Beach California on August 21st 2018 from noon until 2pm. I will be speaking about how ABS’s platform is the only platform that covers all bifurcations.
Please join us, you can RSVP here.